Press Releases

October 12, 2017
Clinical Study Demonstrates that RPS Diagnostics’ FebriDx Rapid Point-of-Care Blood Test Can Accurately Distinguish Between Acute Bacterial and Viral Respiratory Infections in the Outpatient Setting

December 23, 2015
RPS Diagnostics Announces Canadian Approval of FebriDx® Test to Help Rapidly Differentiate Viral from Bacterial Acute Respiratory Infection at the Point of Care

November 2, 2015
RPS Diagnostics to Offer FebriDx™ Point-of-Care Test to Help Rapidly Differentiate Viral from Bacterial Acute Respiratory Infection for Global Distribution at MEDICA

August 4, 2015
RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs

March 17, 2015
RPS Diagnostics Honored with STEMsmart Business Champion Award

November 17, 2014
RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week

October 13, 2014
RPS Secures $28 Million Financing with OrbiMed

October 9, 2014
RPS Announces CE Mark of Rapid, Point-Of-Care Test to Help Detect the Body’s Immune Response to Viral and Bacterial Infections – FebriDx™

July 30, 2014
RPS Welcomes Peter Grady as its New Chief Financial Officer

July 10, 2014
Rapid Pathogen Screening, Inc. restructures Nicox licensing agreement

April 15, 2014
RPS Expands Eye Care Organization in Response to InflammaDry® Regulatory Clearance and Growing Demand

March 25, 2014
RPS Releases Statement on 2014 Conjunctivitis Season Following Recent Outbreak

February 27, 2014
RPS Receives CLIA Waiver for Rapid, Point-of-Care Test for Dry Eye Disease – InflammaDry®

January 21, 2014
RPS Announces Canadian Approval of AdenoPlus® Test to Diagnose Pink Eye

November 25, 2013
RPS Announces FDA Clearance of Rapid, Point-of-Care Test for Dry Eye Disease – InflammaDry®

November 18, 2013
RPS Partners with the CDC for “2013 Get Smart About Antibiotics Week”

September 17, 2013
RPS Marks Growth with Appointment of Industry Experts to Board of Directors

August 20, 2013
RPS Expands Leadership Team with New Marketing Director and VP of Quality Assurance and Regulatory Affairs

July 23, 2013
RPS Receives Private Equity Investment to Accelerate Growth and Facilitate Continued Commercial Success

January 23, 2013
RPS Expands Corporate Headquarters in Sarasota, Florida to Meet Global Demand for POC Diagnostic Tests

December 18, 2012
RPS Receives Nomination for STEMsmart Award

October 12, 2012
FSC Pediatrics Signs License and Distribution Agreement with RPS for Rapid Pink Eye Test

October 5, 2012
RPS Expands Board of Directors with Two New Diagnostic Industry Experts

September 17, 2012
Chris Michaels Joins RPS as Vice President of Strategic Development and Technology Licensing

August 15, 2012
Robert W. Gergen Joins RPS as Vice President of Sales to lead U.S. Sales Initiatives

July 13, 2012
Robert Sambursky Appointed as RPS Chief Executive Officer

June 21, 2012
NicOx Signs Worldwide Licensing Agreement with Rapid Pathogen Screening, Inc. for Ophthalmic Diagnostics

May 22, 2012
RPS Announces Global Ocular Business Expansion with the Hiring of Lori Kagan as Ocular Products Manager

May 2, 2012
RPS Awarded DHS Contract to Develop Rapid Diagnostic Tests

April 25, 2012
RPS Receives CLIA Waiver for New AdenoPlus®

April 18, 2012
Prominent Diagnostics Executive, Douglas W. Berg, Appointed to RPS Board of Directors

February 17, 2012
U.S. Biotech Company Donates Chemical Warfare Diagnostic to Syrian People

January 18, 2012
RPS Appoints Mark D. Myslinski Chief Executive Officer

December 16, 2011
RPS Announces Changes in Board of Directors

September 26, 2011
RPS Wins Top Sarasota Innovator Award

August 18, 2011
RPS Announces Health Canada Approval of RPS InflammaDry Detector™

May 23, 2011
RPS Announces FDA 510(k) Clearance for RPS Adeno Detector Plus™

May 18, 2011
RPS Chief Medical Officer Quoted in Readers Digest Magazine

April 1, 2011
RPS Announces Partnership with Leading Korean Biopharmaceutical Giant, Celltrion

March 7, 2011
RPS Earns ISO 13485 Certification for Quality Management System